Truly disappointed in the development of the site - Lead Scientist Catalent Pharma Employee Review

1.0
9 Oct 2012
Recommend
CEO approval
Business outlook

Pros

Diverse work force, challenging work and customers. There are opportunities to improve many processes and procedures. The vacation is fairly generouse (just don't expect to be able to use it all) and the medical/dental coverage is average. They have cookies on Fridays.

Cons

No caeer development, only training on different techniques to fill in for the other cogs that are continually leaving. Continually pulling work forward to pad monthly numbers instead of using that time to improve efficiencies. And those padded numbers help management make their bonus of which most salaried employees are eligible for. And the continual pandering by senior manangement about engagement, improvement, development, etc - the lip service is annoying and incessant.

Explore other reviews about Catalent Pharma

5.0
26 May 2026
Recommend
CEO approval
Business outlook

Pros

The team is incredibly welcoming, knowledgeable, and supportive, which has made it easy to learn and feel comfortable asking questions. There is a strong focus on training and collaboration, helping me feel safe, well prepared, and confident in my role. I also appreciate the benefits, which support a good work-life balance.

Cons

One area for improvement is the flexibility for new employees regarding remote work hours.

1.0
26 Feb 2026
Recommend
CEO approval
Business outlook

Pros

-Colleagues in labs and manufacturing sites are knowledgeable, dedicated, and supportive of one another. - Compensation and benefits remain competitive within the contract development and manufacturing industry. - Employees gain meaningful hands-on experience with advanced gene therapy and biologics projects. - Certain facilities feature modern equipment that supports complex production requirements. - Occasional team events and basic perks help build occasional positive moments in the workplace.

Cons

- The executive team consists primarily of finance professionals with limited direct experience in biopharmaceutical operations and quality systems. - Substantial debt accumulation and strategic divestitures occurred without sufficient investment in core manufacturing infrastructure or process improvements. - High employee turnover and repeated layoffs have led to increased workloads, reduced staffing levels, and declining team morale. - Persistent gaps in training, documentation, and maintenance contribute to quality deviations and regulatory compliance difficulties. - Communication between departments is often limited, resulting in unrealistic timelines and frequent project delays. - The company faced significant financial pressures approaching instability prior to the private acquisition. - Professional development opportunities are minimal, recognition is inconsistent, and work-life balance remains challenging for most roles

4
See reviews by: Helpful|Rating|Date|All